Breaking News

Horizon appoints CBO

By Kristin Brooks | March 5, 2014

Carey brings extensive healthcare investment banking experience

Robert F. Carey has been appointed executive vice president and chief business officer at Horizon Pharma, Inc. Mr. Carey brings extensive healthcare investment banking experience having assisted biotech and specialty pharma companies raise more than $10 billion in initial public offerings, follow-on offerings, debt offerings and private placements. He has also served as a financial advisor on mergers, acquisitions and strategic alliances.
Mr. Carey joins the company from JMP Securities LLC, where spent more than 11 years as managing director and head of the life sciences investment banking group. Prior to JMP, Mr. Carey was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and Vector Securities, and held roles at Red Hen Bread, InStadium, Shearson Lehman Hutton and Ernst & Whinney.
"Bob's tremendous industry and deal-making experience will be invaluable to us as we look to expand our business through acquisitions of products and companies," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma. "With our focus on acquiring additional innovative medicines or companies that complement our products and leverage our commercial infrastructure, Bob is a key addition to our executive team."
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments